trending Market Intelligence /marketintelligence/en/news-insights/trending/qyaboymhb0xzxo3-egxkag2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Scythian Biosciences to commence trading on Canadian Securities Exchange

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Scythian Biosciences to commence trading on Canadian Securities Exchange

Scythian Biosciences Corp. said its stock will start trading on the Canadian Securities Exchange starting Aug. 15.

The Toronto-based cannabis company's stock, which is also listed in Frankfurt and the OTC Market, will trade under the symbol SCYB.

"The TSX Venture Exchange policies required that we delist from the exchange prior to completion of any acquisitions of United States based cannabis companies. With our strategic expansion into the United States, it was determined best to delist from the TSX Venture Exchange at this point in time," Scythian CEO Rob Reid said in a statement.